Interaction between Alzheimer’s Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

Interaction between Alzheimer’s Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

Alzheimer’s disease (AD) is characterized by the presence of β-amyloid (Aβ) and tau, and subcortical vascular cognitive impairment (SVCI) is characterized by cerebral small vessel disease (CSVD). They are the most common causes of cognitive impairment in the elderly population. Concurrent CSVD burde...

Full description

Bibliographic Details
Main Authors:	Si Eun Kim, Hee Jin Kim, Hyemin Jang, Michael W. Weiner, Charles DeCarli, Duk L. Na, Sang Won Seo
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	International Journal of Molecular Sciences
Subjects:	subcortical vascular cognitive impairment Alzheimer’s disease ß-Amyloid tau cerebral small vessel disease interaction
Online Access:	https://www.mdpi.com/1422-0067/23/18/10490

Similar Items

Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases
by: Ju-Yeun Lee, et al.
Published: (2020-06-01)

Monoclonal Antibody Therapy in Alzheimer’s Disease
by: Monica Neațu, et al.
Published: (2023-12-01)

Mixed Small Vessel Disease in a Patient with Dementia with Lewy Bodies
by: George P. Paraskevas, et al.
Published: (2019-07-01)

Neuroimaging Characteristics of Small-Vessel Disease in Older Adults with Normal Cognition, Mild Cognitive Impairment, and Alzheimer Disease
by: Alberto Mimenza-Alvarado, et al.
Published: (2018-05-01)

Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report
by: A. Wallin, et al.
Published: (2017-05-01)

Potential of brain age in identifying early cognitive impairment in subcortical small-vessel disease patients
by: Yachen Shi, et al.
Published: (2022-09-01)

Effects of Alzheimer’s and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer’s Disease
by: Wha Jin Lee, et al.
Published: (2021-02-01)

Alzheimer’s disease biomarkers in cerebrospinal fluid are stable with the Elecsys immunoassay to most pre-analytical influencing factors except freezing at -80 °C
by: Franz Felix Konen, et al.
Published: (2023-06-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
by: Kaden L. Nystuen, et al.
Published: (2024-01-01)

New Therapeutic Targets in Alzheimer's Disease
by: Horia Coman, et al.
Published: (2017-03-01)

Effects of Subcortical Atrophy and Alzheimer’s Pathology on Cognition in Elderly Type 2 Diabetes: The Alzheimer’s Disease Neuroimaging Initiative Study
by: Wen Zhang, et al.
Published: (2022-01-01)

Cerebral Small Vessel Disease: Cognition, Mood, Daily Functioning, and Imaging Findings from a Small Pilot Sample
by: John G. Baker, et al.
Published: (2012-04-01)

Biochemical markers of neurodegeneration in patients with cerebral small vessel disease and Alzheimer's disease
by: Larisa A. Dobrynina, et al.
Published: (2023-09-01)

Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment
by: Hang-Rai Kim, et al.
Published: (2023-04-01)

Altered serum amyloid beta and cerebral perfusion and their associations with cognitive function in patients with subcortical ischemic vascular disease
by: Wei Zhang, et al.
Published: (2022-10-01)

High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer’s Disease Patients but Not in Non-Alzheimer’s Disease Dementia
by: Giulia Bivona, et al.
Published: (2022-09-01)

Alzheimer’s disease and anesthesia
by: Marie-Amélie ePapon, et al.
Published: (2011-01-01)

Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease
by: Philip Benjamin, et al.
Published: (2014-01-01)

Stage-dependent differential influence of metabolic and structural networks on memory across Alzheimer’s disease continuum
by: Kok Pin Ng, et al.
Published: (2022-09-01)

Clinical features and imaging markers of small vessel disease in symptomatic acute subcortical cerebral microinfarcts
by: Wendan Tao, et al.
Published: (2022-08-01)

The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
by: Christina E. Murray, et al.
Published: (2018-07-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
by: Christopher J. Weber, et al.
Published: (2021-01-01)

Clinical practice guideline for cognitive impairment of cerebral small vessel disease
by: Dantao Peng, et al.
Published: (2019-06-01)

Review of neuroimaging research progress of cerebral small vessel disease
by: Junlin Wang, et al.
Published: (2023-01-01)

The correlation between clinic and neuroimaging of cerebral small vessel disease
by: Zheng⁃qi LU
Published: (2019-07-01)

Cognitive profile in cerebral small vessel disease: comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy
by: Eleonora Barucci, et al.
Published: (2024-03-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Pathological correlates of impaired self-awareness of memory function in Alzheimer’s disease
by: Geoffroy Gagliardi, et al.
Published: (2021-06-01)

Gram-negative bacteria and their lipopolysaccharides in Alzheimer’s disease: pathologic roles and therapeutic implications
by: Hyeon soo Kim, et al.
Published: (2021-12-01)

Genipin and pyrogallol: Two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease
by: Sujin Kim, et al.
Published: (2023-12-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
by: Jean-Marie eSontag, et al.
Published: (2014-03-01)

Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer’s Disease
by: Jiyoung Kim
Published: (2021-03-01)

Cerebral Small Vessel Disease and Alzheimer's Disease: A Review
by: Hae Won Kim, et al.
Published: (2020-08-01)

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
by: Cassia R. Overk, et al.
Published: (2009-09-01)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
by: Yuanxin Zhao, et al.
Published: (2022-07-01)

Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum
by: Mark A. Dubbelman, et al.
Published: (2023-07-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)

Increased CSF levels of total Tau in patients with subcortical cerebrovascular pathology and cognitive impairment
by: Márcia Radanovic, et al.

Apolipoprotein E ε4 and ε3 alleles associate with cerebrospinal fluid tau and cognition in the presence of amyloid-𝜷 in mild cognitive impairment but not in Alzheimer’s disease
by: Feng Xing, et al.
Published: (2021-06-01)